No Data
No Data
No Data
No Data
No Data
NanoVibronix Inc Highlights 2023 Performance and Updates
TipRanksApr 10 04:24
NanoVibronix Q4 2023 Revenue ~$1.2M
NanoVibronix Q4 2023 Revenue ~$1.2M
BenzingaApr 9 20:56
NanoVibronix Issues Letter To Stockholders
We are committed to our strategic vision of developing, improving and commercializing our distinct and effective therapies, which we believe enable healthcare providers to treat patients in need, fill
BenzingaApr 9 20:55
NanoVibronix Enhances Products With Veranex Partnership
TipRanksMar 28 21:22
NanoVibronix Signs Agreement For Research And Development Of Next Generation PainShield And UroShield
Efforts Focused on Adding Therapeutic Functionality and Reducing CostsNanoVibronix, Inc. (NASDAQ:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield, PainShie
BenzingaMar 28 20:36
NanoVibronix Shares Resume Trade
NanoVibronix Shares Resume Trade
BenzingaJan 26 00:14
No Data
No Data